These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33819510)

  • 1. Efficacy of medical treatments for vernal keratoconjunctivitis: A systematic review and meta-analysis.
    Roumeau I; Coutu A; Navel V; Pereira B; Baker JS; Chiambaretta F; Bremond-Gignac D; Dutheil F
    J Allergy Clin Immunol; 2021 Sep; 148(3):822-834. PubMed ID: 33819510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta-analyses.
    Rasmussen MLR; Schou MG; Bach-Holm D; Heegaard S; Jørgensen CAB; Kessel L; Wiencke AK; Subhi Y
    Acta Ophthalmol; 2022 Feb; 100(1):35-44. PubMed ID: 33779061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic options in vernal keratoconjunctivitis].
    Messmer EM
    Ophthalmologe; 2009 Jun; 106(6):557-61. PubMed ID: 19430798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of topical immunomodulators enhance clinical signs of vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC): a meta-analysis.
    Erdinest N; Noyman DBE; London N; Lavy I; Levinger N; Landau D; Solomon A; Morad Y; Naroo SA
    Int Ophthalmol; 2024 Mar; 44(1):157. PubMed ID: 38522059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.
    Vichyanond P; Kosrirukvongs P
    Curr Allergy Asthma Rep; 2013 Jun; 13(3):308-14. PubMed ID: 23625179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis of randomised clinical trials on topical treatments for vernal keratoconjunctivitis.
    Mantelli F; Santos MS; Petitti T; Sgrulletta R; Cortes M; Lambiase A; Bonini S
    Br J Ophthalmol; 2007 Dec; 91(12):1656-61. PubMed ID: 17588996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of eye allergies].
    Kari O; Saari KM
    Duodecim; 2012; 128(3):291-7. PubMed ID: 22428383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 2% Rebamipide Suspension for Vernal Keratoconjunctivitis: A Clinical Comparison with Topical Immune Modulators Cyclosporine and Tacrolimus.
    Malhotra C; Singh H; Jain AK; Gupta A; Ram J
    Ocul Immunol Inflamm; 2022 Jul; 30(5):1083-1091. PubMed ID: 33764241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vernal keratoconjunctivitis in Thailand.
    Kosrirukvongs P; Vichyanond P; Wongsawad W
    Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of topical cyclosporine A 0.05% in vernal keratoconjunctivitis.
    Yücel OE; Ulus ND
    Singapore Med J; 2016 Sep; 57(9):507-10. PubMed ID: 26768065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years.
    Kim SE; Nowak V; Quartilho A; Larkin F; Hingorani M; Tuft S; Dahlmann-Noor A
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013298. PubMed ID: 33084033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis.
    Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H
    J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis.
    Mishra GP; Tamboli V; Jwala J; Mitra AK
    Recent Pat Inflamm Allergy Drug Discov; 2011 Jan; 5(1):26-36. PubMed ID: 21171952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vernal keratoconjunctivitis].
    Pleyer U; Leonardi A
    Ophthalmologe; 2015 Feb; 112(2):177-89; quiz 190-1. PubMed ID: 25591901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ocular cytology in vernal keratoconjunctivitis.
    Bruschi G; Ghiglioni DG; Osnaghi S; Rosazza C; Pires Marafon D; Landi M; Marchisio PG
    Immun Inflamm Dis; 2020 Mar; 8(1):3-7. PubMed ID: 31804769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical tacrolimus for allergic eye diseases.
    Erdinest N; Ben-Eli H; Solomon A
    Curr Opin Allergy Clin Immunol; 2019 Oct; 19(5):535-543. PubMed ID: 31169598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis].
    Doan S; Gabison E; Abitbol O; Gatinel D; Chast F; Hoang-Xuan T
    J Fr Ophtalmol; 2007 Sep; 30(7):697-701. PubMed ID: 17878822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.